Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Jun 22;342(25):1887-92.
doi: 10.1056/NEJM200006223422507.

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Affiliations
Comparative Study

Randomized, controlled trials, observational studies, and the hierarchy of research designs

J Concato et al. N Engl J Med. .

Abstract

Background: In the hierarchy of research designs, the results of randomized, controlled trials are considered to be evidence of the highest grade, whereas observational studies are viewed as having less validity because they reportedly overestimate treatment effects. We used published meta-analyses to identify randomized clinical trials and observational studies that examined the same clinical topics. We then compared the results of the original reports according to the type of research design.

Methods: A search of the Medline data base for articles published in five major medical journals from 1991 to 1995 identified meta-analyses of randomized, controlled trials and meta-analyses of either cohort or case-control studies that assessed the same intervention. For each of five topics, summary estimates and 95 percent confidence intervals were calculated on the basis of data from the individual randomized, controlled trials and the individual observational studies.

Results: For the five clinical topics and 99 reports evaluated, the average results of the observational studies were remarkably similar to those of the randomized, controlled trials. For example, analysis of 13 randomized, controlled trials of the effectiveness of bacille Calmette-Guérin vaccine in preventing active tuberculosis yielded a relative risk of 0.49 (95 percent confidence interval, 0.34 to 0.70) among vaccinated patients, as compared with an odds ratio of 0.50 (95 percent confidence interval, 0.39 to 0.65) from 10 case-control studies. In addition, the range of the point estimates for the effect of vaccination was wider for the randomized, controlled trials (0.20 to 1.56) than for the observational studies (0.17 to 0.84).

Conclusions: The results of well-designed observational studies (with either a cohort or a case-control design) do not systematically overestimate the magnitude of the effects of treatment as compared with those in randomized, controlled trials on the same topic.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Range of Point Estimates According to Type of Research Design. The studies evaluated bacille Calmette–Guérin vaccine and active tuberculosis (13 randomized, controlled trials and 10 case–control studies), screening mammography and mortality from breast cancer (8 randomized, controlled trials and 4 case–control studies), cholesterol levels and death due to trauma among men (4 of 6 randomized, controlled trials [2 trials did not provide point estimates]; the results of the 14 cohort studies were not reported individually), treatment of hypertension and stroke among only the men in the studies (11 randomized, controlled trials and 7 cohort studies), and treatment of hypertension and coronary heart disease among only the men in the studies (13 of 14 randomized, controlled trials [1 trial did not provide point estimates] and 9 cohort studies). Solid circles indicate randomized, controlled trials, and open circles observational studies.

Comment in

Similar articles

Cited by

References

    1. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ. 1948;2:769–82. - PMC - PubMed
    1. Byar DP, Simon RM, Friedewald WT, et al. Randomized clinical trials: perspectives on some recent ideas. N Engl J Med. 1976;295:74–80. - PubMed
    1. Feinstein AR. Current problems and future challenges in randomized clinical trials. Circulation. 1984;70:767–74. - PubMed
    1. Abel U, Koch A. The role of randomization in clinical studies: myths and beliefs. J Clin Epidemiol. 1999;52:487–97. - PubMed
    1. Sacks H, Chalmers TC, Smith H., Jr Randomized versus historical controls for clinical trials. Am J Med. 1982;72:233–40. - PubMed

Publication types